KIORA PHARMACEUTICALS, INC. - Common Stock, $0.01 par value (KPRX)

CUSIP: 49721T507

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 3 signals
Share change
0
SEC-reported price per share
$2.50
Number of holders
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,439,655

Security key

49721T507

Report period

Q3 2026

Institutions

1

Top holders

2

Ownership snapshot

Top reported holders of KPRX - KIORA PHARMACEUTICALS, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
8/15
Latest evidence
10 Sep 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 7 rows are not safely comparable across share classes. 13D/G row: Nantahala Capital Management, LLC Showing 1-6 of 15 holder rows.

Quick read

Nantahala Capital Management, LLC leads the comparable SEC ownership view at 10%.

8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership Top 5
Nantahala Capital Management, LLC 10%
PERCEPTIVE ADVISORS LLC 10%
Alyeska Investment Group, L.P. 10%
ADAR1 Capital Management, LLC 9.9%
Rosalind Advisors, Inc. 9.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nantahala Capital Management, LLC
13D/G
10%
Reported 13D/G · 30 Jun 2026
$1,293,619
491,889 shares
+$140,489 30 Jun 2026
PERCEPTIVE ADVISORS LLC
13D/G 13F
Company
10%
Reported 13D/G · 06 Apr 2026
$1,163,434
442,387 shares
$0 06 Apr 2026
Alyeska Investment Group, L.P.
13D/G
10%
Reported 13D/G · 31 Mar 2026
$852,483
394,668 shares
+$689,126 31 Mar 2026
ADAR1 Capital Management, LLC
13D/G 13F
ADAR1 Capital Management GP, LLC · Company
9.9%
Reported 13D/G · 30 Jun 2026
$1,250,197
475,378 shares
+$289,812 30 Jun 2026
Rosalind Advisors, Inc.
13D/G
9.9%
Reported 13D/G · 31 Dec 2025
—
464,676 shares
$0 31 Dec 2025
Baselake Partners, LP
13D/G
5.8%
Reported 13D/G · 10 Sep 2026
$677,225
257,500 shares
$0 10 Sep 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
2
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
22
Q3 2026 holders
1
Holder diff
-21
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .